Cytokinetics
CYTK
#2440
Rank
NZ$12.90 B
Marketcap
NZ$92.64
Share price
-1.32%
Change (1 day)
-20.05%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): NZ-$10.57

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is NZ-$11.02. In 2025 the company made an earnings per share (EPS) of NZ-$11.91 a decrease over its 2024 EPS that were of NZ-$9.60.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$10.57-11.31%
2025NZ-$11.9124.14%
2024NZ-$9.60-3.49%
2023NZ-$9.9428.24%
2022NZ-$7.7550.18%
2021NZ-$5.1640.8%
2020NZ-$3.67
2018NZ-$3.56-24.12%
2017NZ-$4.69-776.32%
2016NZ$0.69-139.18%
2015NZ-$1.77125.58%
2014NZ-$0.78-67.67%
2013NZ-$2.43-44.58%
2012NZ-$4.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$31.71-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ-$63.38 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.73-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$91.78 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ-$2.10-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA